Tryp Therapeutics Inc (TSE:TRYP)
CNQX:TRYP

Tryp Therapeutics Inc (TRYP) Technical Analysis

14 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
16Bullish
3Neutral
2Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
1Neutral
0Bearish
Tryp Therapeutics Inc’s (TRYP) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Tryp Therapeutics Inc is a Buy.
Tryp Therapeutics Inc’s (TRYP) 20-Day exponential moving average is 0.06, while Tryp Therapeutics Inc’s (TRYP) share price is <C$0.1, making it a Buy.
Tryp Therapeutics Inc’s (TRYP) 50-Day exponential moving average is 0.05, while Tryp Therapeutics Inc’s (TRYP) share price is <C$0.1, making it a Buy.

Tryp Therapeutics Inc (TRYP) Pivot Points

Jul 24, 2024, 04:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Fibonacci
0.06
0.06
0.06
0.06
0.06
0.06
0.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tryp Therapeutics Inc (TRYP) Moving Averages

Jul 24, 2024, 04:08 PM
Period
Simple
Exponential
MA5
0.06Buy
0.06Buy
MA10
0.06Buy
0.06Buy
MA20
0.06Neutral
0.06Buy
MA50
0.04Buy
0.05Buy
MA100
0.04Buy
0.05Buy
MA200
0.05Buy
0.05Buy
Tryp Therapeutics Inc’s (TRYP) 10-Day exponential moving average is 0.06, while Tryp Therapeutics Inc’s (TRYP) share price is <C$0.1, making it a Buy.
Tryp Therapeutics Inc’s (TRYP) 100-Day exponential moving average is 0.05, while Tryp Therapeutics Inc’s (TRYP) share price is <C$0.1, making it a Buy.
Tryp Therapeutics Inc’s (TRYP) stock price is <C$0.1 and Tryp Therapeutics Inc’s (TRYP) 50-day simple moving average is 0.04, creating a Buy signal.
Tryp Therapeutics Inc’s (TRYP) stock price is <C$0.1 and Tryp Therapeutics Inc’s (TRYP) 100-day simple moving average is 0.04, creating a Buy signal.
Tryp Therapeutics Inc’s (TRYP) stock price is <C$0.1 and Tryp Therapeutics Inc’s (TRYP) 200-day simple moving average is 0.05, creating a Buy signal.

Tryp Therapeutics Inc (TRYP) Technical Indicators

Jul 24, 2024, 04:08 PM
Name
Value
Implied Action
RSI (14)
68.27
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
16.67
Buy
MACD (12,26)
<0.01
Buy
ADX (14)
50.72
Sell
Williams %R
-100.00
Buy
CCI (14)
25.23
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
-19.23
Sell
ROC
0.00
-
Tryp Therapeutics Inc’s (TRYP) Relative Strength Index (RSI) is 68.27, creating a Neutral signal.
Tryp Therapeutics Inc’s (TRYP) Trend Strength Indicator (ADX) is 50.72, creating a Sell signal.
Tryp Therapeutics Inc’s (TRYP) Commodity Channel Index (CCI) is 25.23, creating a Neutral signal.

FAQ

Is TRYP a Buy, Hold, or Sell?
Based on TRYP’s technical indicators, TRYP is a Strong Buy.
    What is TRYP’s RSI (14)?
    TRYP’s RSI (14) is 68.27, which suggests TRYP is a Neutral.
      What is TRYP’s MACD?
      TRYP’s MACD is <0.01, which suggests TRYP is a Buy.
        What is TRYP’s 5-day moving average?
        TRYP’s 5-day moving average is 0.06, which suggests TRYP is a Buy.
          What is TRYP’s 20-day moving average?
          TRYP 20-day moving average is 0.06, which suggests TRYP is a Neutral.
            What is TRYP’s 50-day moving average?
            TRYP’s 50-day moving average is 0.04, which suggests TRYP is a Buy.
              What is TRYP’s 200-day moving average?
              TRYP’s 200-day moving average is 0.05, which suggests TRYP is a Buy.
                What is TRYP’s Williams % R (14)?
                TRYP’s Williams % R (14) is -100.00, which suggests TRYP is a Buy.
                  What is TRYP’s CCI (14)?
                  TRYP’s CCI (14) is 25.23, which suggests TRYP is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis